Shandong Buchang Pharmaceuticals Co., Ltd. (SHA: 603858)
China flag China · Delayed Price · Currency is CNY
17.30
-0.15 (-0.86%)
Nov 13, 2024, 3:00 PM CST

Shandong Buchang Pharmaceuticals Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Operating Revenue
11,76013,22914,94215,75515,98314,245
Upgrade
Other Revenue
16.6216.629.627.3623.2410.86
Upgrade
Revenue
11,77613,24514,95115,76316,00714,255
Upgrade
Revenue Growth (YoY)
-13.60%-11.41%-5.15%-1.52%12.28%4.32%
Upgrade
Cost of Revenue
4,8434,3214,2684,1343,7392,388
Upgrade
Gross Profit
6,9348,92410,68311,62912,26811,867
Upgrade
Selling, General & Admin
5,7227,3658,3879,2379,2128,886
Upgrade
Research & Development
364.27335.08284.12408.6533.42505.36
Upgrade
Other Operating Expenses
271.8181.03232.07226.9234.55222.42
Upgrade
Operating Expenses
6,3627,8898,9079,8889,9819,591
Upgrade
Operating Income
571.871,0351,7761,7412,2872,276
Upgrade
Interest Expense
-119.84-109.93-135.1-167.29-145.05-136.78
Upgrade
Interest & Investment Income
13.240.1222.6141.3432.977.88
Upgrade
Currency Exchange Gain (Loss)
0.080.080.45-0.120.040.07
Upgrade
Other Non Operating Income (Expenses)
-61.86-9.87-11.43-6.739.56.27
Upgrade
EBT Excluding Unusual Items
403.45955.881,6521,6082,1842,223
Upgrade
Impairment of Goodwill
-598.03-598.03-2,943-10.15-0.24-
Upgrade
Gain (Loss) on Sale of Investments
-1.96-2.36-56.79-60--
Upgrade
Gain (Loss) on Sale of Assets
-3.09-2.47-0.66-0.59-0.54-3.45
Upgrade
Asset Writedown
-26.62-0.3---0.02
Upgrade
Other Unusual Items
41.8441.8488.51176.49177.25194.88
Upgrade
Pretax Income
-184.4394.56-1,2591,7142,3612,415
Upgrade
Income Tax Expense
277.09242.69331.59478.29517.55451.48
Upgrade
Earnings From Continuing Operations
-461.49151.87-1,5911,2351,8431,963
Upgrade
Minority Interest in Earnings
168.19167.1161.2453.8417.75-17.23
Upgrade
Net Income
-293.31318.97-1,5301,2891,8611,946
Upgrade
Net Income to Common
-293.31318.97-1,5301,2891,8611,946
Upgrade
Net Income Growth
----30.72%-4.37%3.05%
Upgrade
Shares Outstanding (Basic)
1,0941,1061,1061,1061,1061,116
Upgrade
Shares Outstanding (Diluted)
1,0941,1061,1061,1061,1061,116
Upgrade
Shares Change (YoY)
-1.09%-0.00%-0.01%0.00%-0.87%-2.26%
Upgrade
EPS (Basic)
-0.270.29-1.381.171.681.74
Upgrade
EPS (Diluted)
-0.270.29-1.381.171.681.74
Upgrade
EPS Growth
----30.72%-3.54%5.43%
Upgrade
Free Cash Flow
584.82-725.522,212886.981,4221,959
Upgrade
Free Cash Flow Per Share
0.53-0.662.000.801.291.76
Upgrade
Dividend Per Share
0.1260.1260.9600.3600.5261.614
Upgrade
Dividend Growth
-86.88%-86.88%166.67%-31.56%-67.41%69.01%
Upgrade
Gross Margin
58.88%67.38%71.45%73.77%76.64%83.25%
Upgrade
Operating Margin
4.86%7.82%11.88%11.04%14.29%15.96%
Upgrade
Profit Margin
-2.49%2.41%-10.23%8.18%11.63%13.65%
Upgrade
Free Cash Flow Margin
4.97%-5.48%14.80%5.63%8.89%13.74%
Upgrade
EBITDA
930.241,4462,2562,2332,7112,662
Upgrade
EBITDA Margin
7.90%10.92%15.09%14.17%16.94%18.67%
Upgrade
D&A For EBITDA
358.36410.47479.96492.39424.55386.08
Upgrade
EBIT
571.871,0351,7761,7412,2872,276
Upgrade
EBIT Margin
4.86%7.82%11.88%11.04%14.29%15.96%
Upgrade
Effective Tax Rate
-61.51%-27.91%21.92%18.70%
Upgrade
Revenue as Reported
11,77613,24514,95115,76316,00714,255
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.